FDA Approves Philips’ PET and MRI Whole Body Scanning System

The FDA has approved Philips’ whole body scanning system that uses both PET, or positron emission tomography, and MRI, to detect cancer, according to a Washington Post report.

Advertisement

PET identifies cancer cells as they absorb chemical tracers, and MRI views the surrounding tissue. Philips spokesman Steve Klink compared the PET to a GPS system and MRI to the map.

Related Articles on Medical Devices:

FDA Approves New Boston Scientific Heart Stent
Doctors Question the Value of Robot-Assisted Surgery
FDA’s Dr. Jeffrey Shuren Speaks to Congress About Medical Device Approval

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.